| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Purchases of capped call transactions | - | - | - | 0 |
| Net cash used in financing activities | -164,200 | 10,800 | 12,500 | -733,200 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 17,700 | 18,800 | 2,300 | 3,800 |
| Increase in cash, cash equivalents and restricted cash | 1,229,600 | 553,000 | 298,800 | 54,900 |
| Cash and cash equivalents at beginning of period | 607,300 | - | - | - |
| Cash and cash equivalents at end of period | 1,836,900 | - | - | - |
DEXCOM INC (DXCM)
DEXCOM INC (DXCM)